Please login to the form below

Not currently logged in
Email:
Password:

TauRx

This page shows the latest TauRx news and features for those working in and with pharma, biotech and healthcare.

Another amyloid bust as Roche pulls crenezumab trials

Another amyloid bust as Roche pulls crenezumab trials

AD have also yielded disappointing results for companies including TauRx, Zeltia, Bristol-Myers Squibb and Allon/Paladin Labs.

Latest news

  • Lilly partners with AC Immune on tau drug for Alzheimer’s Lilly partners with AC Immune on tau drug for Alzheimer’s

    The company credited with pioneering the tau hypothesis in AD is TauRx, although its aggregation inhibitor LMTX disappointed in an 891-paient phase 3 trial reported in 2016.

  • AbbVie takes anti-tau drug into phase II for Alzheimer's AbbVie takes anti-tau drug into phase II for Alzheimer's

    Whether tau-targeting drugs can do better remains to be seen. Last year, TauRx's tau aggregation inhibitor LMTX failed to slow cognitive decline in three phase III trials - two in ... TauRx also said it had cognitive benefit in a subset of patients not

  • Tau protein drug fails late-stage trial Tau protein drug fails late-stage trial

    year. TauRx' tau aggregation inhibitor LMTX failed to meet its objective of improving cognition and the ability to carry out everyday tasks in the trial, which involved 891 patients with mild ... TauRx has two other trials in play – one in mild

  • AbbVie and C2N take tau antibody into clinic AbbVie and C2N take tau antibody into clinic

    Other companies working on tau as a target include TauRx Therapeutics, which has a phase III trial ongoing of its lead candidate LTX in Alzheimer's and is due to report

  • Alzheimer's disease pipeline takes multiple hits Alzheimer's disease pipeline takes multiple hits

    Of these, TRx 0237 (leuco-methylthioninium, TauRx Pharmaceuticals), an oral agent shown to inhibit tau aggregation, is in phase III trials in the US and the UK in patients with ... Two agents targeting tau have been discontinued recently at phase II –

More from news
Approximately 2 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...
The Future of Pharma sales: fast forward to 2029
Change is inevitable, and necessary, for growth in business....
International Women's Day - 8 March 2019
International Women's Day has been celebrated since its inception in 1911. But how far have we come?...

Infographics